LifeMD, Inc. (LFMDP) stock
LFMDPNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 10/3099% above fair value
$21.65+0.13 (+0.60%)
Close on Oct 30, 2026Market cap $110.38MP/E –Yield –
LifeMD operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
LifeMD's operating income for the twelve months ending Jun 30, 2026 was -$24.25M. For fiscal 2025 it was -$7.67M. The highest annual figure on record is -$262.22K in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.67M | – |
| FY2024 | Dec 31, 2024 | -$20.40M | – |
| FY2023 | Dec 31, 2023 | -$14.49M | – |
| FY2022 | Dec 31, 2022 | -$43.45M | – |
| FY2021 | Dec 31, 2021 | -$54.30M | – |
| FY2020 | Dec 31, 2020 | -$57.82M | – |
| FY2019 | Dec 31, 2019 | -$2.89M | – |
| FY2018 | Dec 31, 2018 | -$2.06M | – |
| FY2017 | Dec 31, 2017 | -$1.23M | – |
| FY2016 | Dec 31, 2016 | -$1.17M | – |
| FY2015 | Dec 31, 2015 | -$262.22K | – |
| FY2014 | Dec 31, 2014 | -$530.88K | – |
| FY2013 | Dec 31, 2013 | -$546.41K | – |
| FY2012 | Dec 31, 2012 | -$540.03K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.93M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.22M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.97M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.18M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.97M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.00M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.31M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.17M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.17M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.57M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.90M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.85M | – |
| Q4 FY2022 | Dec 31, 2022 | -$10.37M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.07M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.90M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.11M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.66M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.59M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.13M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.92M | – |
| Q4 FY2020 | Dec 31, 2020 | -$32.33M | – |
| Q3 FY2020 | Sep 30, 2020 | -$20.53M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.22M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.74M | – |
| Q4 FY2019 | Dec 31, 2019 | -$519.37K | – |
| Q3 FY2019 | Sep 30, 2019 | -$973.71K | – |
| Q2 FY2019 | Jun 30, 2019 | -$833.16K | – |
| Q1 FY2019 | Mar 31, 2019 | -$563.37K | – |
| Q4 FY2018 | Dec 31, 2018 | -$793.70K | – |
| Q3 FY2018 | Sep 30, 2018 | -$385.64K | – |
| Q2 FY2018 | Jun 30, 2018 | -$938.45K | – |
| Q1 FY2018 | Mar 31, 2018 | -$279.31K | – |
| Q4 FY2017 | Dec 31, 2017 | -$354.33K | – |
| Q3 FY2017 | Sep 30, 2017 | -$273.57K | – |
| Q2 FY2017 | Jun 30, 2017 | -$380.30K | – |
| Q1 FY2017 | Mar 31, 2017 | -$401.79K | – |
| Q4 FY2016 | Dec 31, 2016 | -$708.25K | – |
| Q3 FY2016 | Sep 30, 2016 | -$207.70K | – |